Pular para o conteúdo principal
Ranking Invest

DHR - Danaher Corporation

Segmento: HealthcareDanaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Análise Ranking Invest

Valuation estimado
$ 66.03 Bi
Valor de Mercado
$ 140.70 Bi
Sobrepreço (AV)+113.1%
IVR
0.47A companhia vale 0,47 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.12O valuation alternativo equivale a 12% do valor de mercado da companhia.
MLL
0.12O lucro líquido dos controladores em 16 trimestres equivale a 12% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 52.57 Bi

Dívida Líquida

$ 27.97 Bi

L4T

$ 4.00 Bi

MM4T

15.92%

Indicadores Básicos

ROE

7.62%

Índices de Previsibilidade

Receita Líquida

C0.07

Lucro

A0.14

Margem

A0.13

Índices de Tendência

Receita Líquida

F-8.24

Lucro

F-7.85

Margem

F-7.53

Índices de Endividamento

DIV/PAT

0.53

DIV/L4T

6.99

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.